HOSE USD

Traphaco Joint Stock Company (TRA.VN)

Compare
76,900.00
-100.00
(-0.13%)
At close: January 23 at 1:46:26 PM GMT+7
Currency in VND All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,318,463,661.92
2,299,235,459.01
2,398,917,958.77
2,160,840,045.54
1,908,870,012.28
Cost of Revenue
1,107,985,429.01
1,054,301,295.26
1,055,721,001.83
1,013,404,064.89
877,456,366.60
Gross Profit
1,210,478,232.91
1,244,934,163.75
1,343,196,956.94
1,147,435,980.65
1,031,413,645.68
Operating Expense
927,887,018.76
911,561,308.54
992,618,493.75
820,854,976.72
762,341,704.56
Operating Income
282,591,214.16
333,372,855.21
350,578,463.20
326,581,003.93
269,071,941.12
Net Non Operating Interest Income Expense
18,820,405.52
25,737,365.87
16,014,096.25
5,013,550.54
-4,980,532.53
Pretax Income
295,327,174.07
360,667,618.76
368,455,950.85
330,710,077.61
266,648,975.01
Tax Provision
62,537,829.53
75,398,700.15
74,940,473.24
66,243,221.47
49,901,397.02
Net Income Common Stockholders
184,845,614.61
229,439,509.00
235,184,734.69
209,901,047.67
195,787,070.07
Diluted NI Available to Com Stockholders
184,845,614.61
229,439,509.00
235,184,734.69
209,901,047.67
195,787,070.07
Basic EPS
4.46k
5.54k
5.67k
5.06k
4.16k
Diluted EPS
4.46k
5.54k
5.67k
5.06k
4.16k
Basic Average Shares
41,450.54
41,450.54
41,450.54
41,450.54
41,450.54
Diluted Average Shares
41,450.54
41,450.54
41,450.54
41,450.54
41,450.54
Total Operating Income as Reported
302,830,607.10
359,455,865.52
366,637,327.74
331,705,720.25
264,660,661.39
Total Expenses
2,035,872,447.77
1,965,862,603.80
2,048,339,495.57
1,834,259,041.62
1,639,798,071.17
Net Income from Continuing & Discontinued Operation
213,012,626.40
263,248,297.79
269,144,864.66
241,590,550.40
195,787,070.07
Normalized Income
213,012,626.40
263,248,297.79
269,144,864.66
241,590,550.40
195,787,070.07
Interest Income
22,880,491.92
29,734,151.65
16,880,952.31
10,181,478.14
5,864,144.34
Interest Expense
4,058,048.95
3,940,136.81
1,087,900.96
5,433,202.65
11,442,619.34
Net Interest Income
18,820,405.52
25,737,365.87
16,014,096.25
5,013,550.54
-4,980,532.53
EBIT
299,385,223.02
364,607,755.57
369,543,851.81
336,143,280.26
278,091,594.35
EBITDA
392,174,454.40
459,106,626.27
456,400,527.73
420,789,407.14
359,855,154.48
Reconciled Cost of Revenue
1,107,985,429.01
1,054,301,295.26
1,055,721,001.83
1,013,404,064.89
877,456,366.60
Reconciled Depreciation
92,789,231.38
94,498,870.70
86,856,675.92
84,646,126.88
81,763,560.14
Net Income from Continuing Operation Net Minority Interest
213,012,626.40
263,248,297.79
269,144,864.66
241,590,550.40
195,787,070.07
Normalized EBITDA
392,174,454.40
459,106,626.27
456,400,527.73
420,789,407.14
359,855,154.48
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 7/17/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DPM.F Sumitomo Pharma Co., Ltd.
3.3600
-2.33%
 
WSG.SG China Traditional Chinese Medicine Holdings Co Ltd
0.2240
0.00%
 
526075.BO 526075.BO,0P0000BXCE,0
4.5000
0.00%
 
EVT.VI Evotec SE
7.97
-0.38%
 
R9U2.F Green Thumb Industries Inc.
6.71
-4.82%
 
SHIEF Shield Therapeutics plc
0.0345
0.00%
 
TLRY.VI Tilray Brands, Inc.
1.0805
-1.73%
 
APPH.DE Apontis Pharma AG
10.20
-1.92%
 
NECLIFE.BO Nectar Lifesciences Limited
39.35
+0.25%
 
STSN Stemsation International, Inc.
0.0090
-10.00%